Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1125 | D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester Wiki | 1.00 |
| drug2084 | LIIT.CI ACT Wiki | 1.00 |
| drug2916 | Placebo Wiki | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Chronic illness (CI) presents a significant and negative effect on quality of life and mental health. Further, emotion regulation has been considered of particular importance on the determination of chronic patients' well-being. Evidence suggests that Acceptance and Commitment Therapy (ACT) is an effective approach to improve psychological health in patients with CI. Further, there is some, although limited, evidence, that self-compassion training may be also useful in this context, and the inclusion of self-compassion elements in ACT interventions has even been the focus of attention by recent studies. Nevertheless, no study yet has compared the efficacy of these two types of intervention in CI. This is the aim of the present project - to analyse, in a low intensity eHealth intervention context, whether ACT or Compassion Focused Therapy (CFT) present superiority over the other in improving mental health and illness-related outcomes in CI.
Description: Higher scores indicate more depression and anxiety symptoms (0-21)
Measure: Depression and anxiety (Hospital Anxiety and Depression Scales; HADS) Time: Changes in results from: immediately pre-intervention and immediately post-intervention assessmentsDescription: Higher scores indicate higher levels of illness shame (0-28)
Measure: Illness shame (Chronic Illness Shame Scale; CISS) Time: Changes in results from: immediately pre-intervention and immediately post-intervention assessmentsDescription: Higher scores indicate higher levels of psychological flexibility (0-108)
Measure: Psychological Flexibility (Comprehensive assessment of ACT processes; CompACT) Time: Changes in results from: immediately pre-intervention and immediately post-intervention assessmentsDescription: Higher scores indicate higher levels of self-compassion (subscale of the Self-compassion scale) (13-65)
Measure: Self-compassion (Self-compassion scale; SCS) Time: Changes in results from: immediately pre-intervention and immediately post-intervention assessmentsDescription: Higher scores indicate higher levels of self-cristicism (subscale of the Self-compassion scale) (13-65)
Measure: Self-criticism (Self-compassion scale; SCS) Time: Changes in results from: immediately pre-intervention and immediately post-intervention assessmentsDescription: Higher scores indicate higher levels of cognitive fusion (0-28)
Measure: Cognitive fusion (Cognitive Fusion Scale; CFQ-7) Time: Changes in results from: immediately pre-intervention and immediately post-intervention assessmentsDescription: Higher scores indicate more fear of contracting COVID-19 (9-45)
Measure: Fear of contracting COVID-19 (Fear of contracting COVID-19 scale; FCCS) Time: Changes in results from: immediately pre-intervention and immediately post-intervention assessmentsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports